Table 2

Imaging characteristics of the study population

VariableTotal population (N=50)VO2 max>median (n=26)VO2 max≤median (n=24)p Value
Echocardiography
Deceleration time (ms)240±79233±79247±800.6
E/E′ ratio8.5±37.7±39.6±30.07
Abnormal diastolic function, n (%)37 (74)17 (65)20 (83)0.2
Left ventricular end-diastolic stiffness (mmHg/ml)0.08±0.030.07±0.030.1±0.030.05
Myocardial performance index0.70±0.450.74±0.530.67±0.360.6
Resting peak LVOT gradient (mmHg)34±37 (IQR 9–43)32±35 (IQR 7–43)36±39 (IQR 10–46)0.7
Provokable (amyl nitrite or Valsalva) peak LVOT gradient (mmHg)85±43 (IQR 54–125)81±53 (IQR 53–113)90±45 (IQR 58–130)0.6
Post stress peak LVOT gradient (mmHg)93±55 (IQR 48–131)99±53 (IQR 57–135)86±56 (IQR 37–127)0.4
Resting mitral regurgitation (0–4+)1±11±11±10.9
Post-stress mitral regurgitation (0–4+)1.5±11.5±11.5±10.9
Cardiac magnetic resonance
Basal end-diastolic septal thickness (cm)1.93±0.5 (IQR 1.6–2.3)1.94±0.5 (IQR 1.6–2.3)1.93±0.5 (IQR 1.6–2.3)0.9
Left atrial area index (cm2/m2)13±312±213±40.1
Left ventricular end-diastolic volume index (ml/m2)87±1790±1984±130.2
Left ventricular end-systolic volume index (ml/m2)32±9342±930±80.1
Left ventricular mass index (g/m2)112±36118±39106±330.2
Left ventricular ejection fraction (%)64±764±764±70.9
Presence of myocardial hyperenhancement, n (%)30 (60)18 (69)12 (50)0.2
End-diastolic ascending aortic area (cm2)4.78±1.24.65±1.44.87±1.10.6
Pulse wave velocity (m/s)9.3±76.7±312.1±90.003
Ascending aortic distensibility (10−3 mmHg−1)4±35±33±70.02
  • Results are shown as mean±SD unless stated otherwise.

  • IQR, interquartile range; LVOT, left ventricular outflow tract.